Home/Filings/4/0001641172-25-015755
4//SEC Filing

Morris Gabriel S 4

Accession 0001641172-25-015755

CIK 0001873835other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 9:35 AM ET

Size

7.3 KB

Accession

0001641172-25-015755

Insider Transaction Report

Form 4
Period: 2025-06-18
Morris Gabriel S
DirectorCFO
Transactions
  • Purchase

    Common Stock

    2025-06-18$2.28/sh+2,225$5,071288,059 total
Holdings
  • Common Stock

    (indirect: See footnote)
    270,844
  • Common Stock

    (indirect: See footnote)
    24,141
Footnotes (3)
  • [F1]Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
  • [F3]Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001889967

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:35 AM ET
Size
7.3 KB